col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


79 Results       Page 1

 [1] 
BMJ: RMD Open
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―10 Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study Hilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton, Ingrid Jyssum, Anne T Tveter, Ingrid E Christensen, et al. (+12)
2 [GO] 2023―Nov―29 COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series Ines Colmegna, Valeria Valerio, Nathalie Amiable, Mariana Useche, Emmanouil Rampakakis, Louis Flamand, et al. (+10)
3 [GO] 2023―Nov―17 COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study Yun Kyu Kim, Ju Yeon Kim, Ji In Jung, Jin Kyun Park, Eun Young Lee, Eun-Bong Lee, Jun Won Park
4 [GO] 2023―Aug―31 Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study Michaela Koehm, Maximilian Klippstein, Stephanie Dauth, Konstantin Hallmann, Niko Kohmer, Harald Burkhardt, et al. (+4)
5 [GO] 2023―Aug―28 Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan Faten Aqeel, Reza Zonozi, Anushya Jeyabalan, Gabriel Sauvage, John L Niles, Duvuru Geetha
6 [GO] 2023―Aug―17 Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims database, 2020-2021 Cassandra Calabrese, Gelareh Atefi, Kristin A Evans, Meghan Moynihan, Liisa Palmer, Sze-Jung Wu
7 [GO] 2023―Jul―21 COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs Jih-Jin Tsai, Li-Teh Liu, Chun-Hong Chen, Liang-Jen Chen, Shiow-Ing Wang, James Cheng-Chung Wei
8 [GO] 2023―Jul―07 Self-evidence-based digital care programme improves health-related quality of life in adults with a variety of autoimmune diseases and long COVID: a retrospective study Nicole Bundy, Mackenzie De Jesus, Millennia Lytle, Leonard Calabrese, Christina Gobin, Mette Dyhrberg
9 [GO] 2023―Jun―16 Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group Francesco Ursini, Piero Ruscitti, Olga Addimanda, Rosario Foti, Vincenzo Raimondo, Giuseppe Murdaca, et al. (+33)
10 [GO] 2023―Apr―17 Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases Rebecca Hasseli, Jutta G. Richter, Bimba Franziska Hoyer, Hanns-Martin Lorenz, Alexander Pfeil, Anne Constanze Regierer, et al. (+19)
11 [GO] 2023―Mar―16 Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2) Ai Phuong Tran, D.F Tassone, N S Ding, Johannes Nossent
12 [GO] 2023―Mar―16 Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study José M Álvaro-Gracia, Carlos Sanchez-Piedra, Dante Culqui, Rosa Rosello, Alicia Garcia-Dorta, Cristina Campos, et al. (+13)
13 [GO] 2023―Mar―08 Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study Xiaofeng Jiang, Jeffrey Sparks, Zachary Wallace, Xinjia Deng, Hui Li, Na Lu, et al. (+6)
14 [GO] 2023―Feb―14 Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case series Chathurika Lakmini Dandeniya, Theekshana Kavinda Premathilake
15 [GO] 2022―Dec―06 Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series Alexander ten Hagen, Elisa Habermann, Sandra Hermann, Gerd R Burmester, Robert Biesen, Fredrik N. Albach
16 [GO] 2022―Dec―06 Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, et al. (+11)
17 [GO] 2022―Dec―02 Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort Marie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, Claire Martin, Mathilde Devaux, Tiphaine Goulenok, et al. (+6)
18 [GO] 2022―Nov―03 Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Joe Sexton, Ingrid Egeland Christensen, Trung T Tran, et al. (+14)
19 [GO] 2022―Oct―10 Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach, Alexander ten Hagen, et al. (+9)
20 [GO] 2022―Oct―10 Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis David Stahl, Carola tho Pesch, Carolin Brück, Ruth L Esser, Jan Thiele, Veronica Di Cristanziano, David M Kofler
21 [GO] 2022―Sep―15 Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registry Casper Webers, Astrid van Tubergen, Harald E Vonkeman, Annelies Boonen
22 [GO] 2022―Sep―14 Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey Michael DiIorio, Kevin Kennedy, Jean W Liew, Michael S Putman, Emily Sirotich, Sebastian E Sattui, et al. (+43)
23 [GO] 2022―Sep―14 Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination Ioana Andreica, Arturo Blazquez-Navarro, Jan Sokolar, Moritz Anft, Uta Kiltz, Stephanie Pfaender, et al. (+5)
24 [GO] 2022―Sep―13 Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry Su-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, Kimme L Hyrich, Anja Strangfeld, Laure Gossec, et al. (+36)
25 [GO] 2022―Sep―13 COVID-19-associated arthritis: an emerging new entity? Bayram Farisogullari, Ana S Pinto, Pedro M Machado
26 [GO] 2022―Sep―12 Reactive arthritis after SARS-CoV-2 infection Sophia Dombret, Alla Skapenko, Hendrik Schulze-Koops
27 [GO] 2022―Sep―09 Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases Michelle W Cheung, Roya M Dayam, Jaclyn C Law, Rogier L Goetgebuer, Gary Y C Chao, Naomi Finkelstein, et al. (+15)
28 [GO] 2022―Sep―07 Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica Yannick van Sleen, Kornelis S M van der Geest, Rosanne D Reitsema, Idil Esen, Janneke H Terpstra, Elisabeth Raveling-Eelsing, et al. (+6)
29 [GO] 2022―Aug―01 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry Saskia Lawson-Tovey, Pedro M Machado, Anja Strangfeld, Elsa Mateus, Laure Gossec, Loreto Carmona, et al. (+7)
30 [GO] 2022―May―23 Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE) Ai Phuong Tran, Daniel Tassone, Johannes Nossent, Nik Sheng Ding
31 [GO] 2022―May―23 COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases Rim Bourguiba, Maeva Kyheng, Isabelle Koné-Paut, Diane Rouzaud, Jerome Avouac, Mathilde Devaux, et al. (+16)
32 [GO] 2022―May―19 Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses Samuel Bitoun, Jérôme Avouac, Julien Henry, Roba Ghossan, Omar Al Tabaa, Rakiba Belkhir, et al. (+6)
33 [GO] 2022―May―19 Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination Filippo Fagni, Katja Schmidt, Daniela Bohr, Larissa Valor-Méndez, Fabian Hartmann, Koray Tascilar, et al. (+6)
34 [GO] 2022―May―10 SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry Jean Liew, Milena Gianfrancesco, Carly Harrison, Zara Izadi, Stephanie Rush, Saskia Lawson-Tovey, et al. (+39)
35 [GO] 2022―May―10 Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? Andrew J Laster, Gordon K Lam, Heather S Gladue, Ahmad A Kashif, Erin P Siceloff, Virginia D Lackey, et al. (+3)
36 [GO] 2022―Apr―12 Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome Gwenny M Verstappen, Liseth de Wolff, Suzanne Arends, Hella-Marie Heiermann, Yannick van Sleen, Annie Visser, et al. (+7)
37 [GO] 2022―Apr―05 Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, et al. (+27)
38 [GO] 2022―Apr―01 Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses Benazir Saleem, Rebecca L Ross, Lesley-Anne Bissell, Aamir Aslam, Kulveer Mankia, Laurence Duquenne, et al. (+17)
39 [GO] 2022―Mar―31 Correction: Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
40 [GO] 2022―Mar―31 Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy Daniel Sidler, Alexander Born, Simeon Schietzel, Michael P Horn, Daniel Aeberli, Jennifer Amsler, et al. (+18)
41 [GO] 2022―Mar―04 Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases George E Fragoulis, Anastasios Karamanakos, Aikaterini Arida, Vasiliki-Kalliopi Bournia, Gerasimos Evangelatos, Antonis Fanouriakis, et al. (+8)
42 [GO] 2022―Feb―07 Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination Paola Adele Lonati, Caterina Bodio, Mariangela Scavone, Giuliana Martini, Elisa Pesce, Alessandra Bandera, et al. (+10)
43 [GO] 2022―Feb―03 Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients Simeon Schietzel, Manuel Anderegg, Andreas Limacher, Alexander Born, Michael P Horn, Britta Maurer, et al. (+3)
44 [GO] 2022―Feb―02 Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy Kathleen MM Vanni, Naomi J Patel, Michael DiIorio, Emily Kowalski, Grace Qian, Claire E Cook, et al. (+3)
45 [GO] 2022―Jan―18 Correction: Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
46 [GO] 2022―Jan―05 Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases Cristiana Sieiro Santos, Sara Calleja Antolin, Clara Moriano Morales, Juan Garcia Herrero, Elvira Diez Alvarez, Fernando Ramos Ortega, Jose G Ruiz de Morales
47 [GO] 2022―Jan―05 Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors Vincenzo Venerito, Pasquale Stefanizzi, Marco Fornaro, Fabio Cacciapaglia, Silvio Tafuri, Simone Perniola, et al. (+2)
48 [GO] 2021―Dec―09 Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study Jose María Álvaro Gracia, Carlos Sanchez-Piedra, Javier Manero, María Ester Ruiz-Lucea, Laura López-Vives, Cristina Bohorquez, et al. (+15)
49 [GO] 2021―Dec―08 Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Gerd-Marfie Ahlenius, Eva Baecklund, et al. (+10)
50 [GO] 2021―Dec―08 Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies Ulf M Geisen, Melike Sümbül, Florian Tran, Dennis K Berner, Hayley M Reid, Lena Vullriede, et al. (+13)
51 [GO] 2021―Dec―03 Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab Cathy Mireille Melong Pianta Taleng, Kim Lauper, Benoit Gilbert, Tim Cunningham, Romain Guemara, Laure Brulhart, et al. (+3)
52 [GO] 2021―Dec―03 Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series Theerada Assawasaksakul, Seelwan Sathitratanacheewin, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Wonngarm Kittanamongkolchai
53 [GO] 2021―Nov―24 Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study Marlou THF Janssen, Sofia Ramiro, Rémy LM Mostard, Cesar Magro-Checa, Robert BM Landewé
54 [GO] 2021―Nov―23 Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials Kedar Gautambhai Mehta, Tejas Patel, Paragkumar D Chavda, Parvati Patel
55 [GO] 2021―Nov―01 Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider Alessia Alunno, Aurélie Najm, Xavier Mariette, Gabriele De Marco, Jenny Emmel, Laura Mason, et al. (+2)
56 [GO] 2021―Sep―07 Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey Sebastian Eduardo Sattui, Jean W Liew, Kevin Kennedy, Emily Sirotich, Michael Putman, Tarin T Moni, et al. (+44)
57 [GO] 2021―Jul―26 Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany Claudia Sengler, Sascha Eulert, Kirsten Minden, Martina Niewerth, Gerd Horneff, Jasmin Kuemmerle-Deschner, et al. (+10)
58 [GO] 2021―May―06 Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review Muhanad Taha, Lobelia Samavati
59 [GO] 2021―May―03 Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry Bente Glintborg, Dorte Vendelbo Jensen, Sara Engel, Lene Terslev, Mogens Pfeiffer Jensen, Oliver Hendricks, et al. (+15)
60 [GO] 2021―Apr―07 Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, et al. (+10)
61 [GO] 2021―Mar―31 COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusions Robert B M Landewé, Sofia Ramiro, Rémy L M Mostard
62 [GO] 2021―Feb―24 Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases Victoria Furer, Christien Rondaan, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, et al. (+7)
63 [GO] 2021―Feb―24 Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines Hendrik Schulze-Koops, Christof Specker, Alla Skapenko
64 [GO] 2021―Feb―23 Digital rheumatology in the era of COVID-19: results of a national patient and physician survey Anna Kernder, Harriet Morf, Philipp Klemm, Diana Vossen, Isabell Haase, Johanna Mucke, et al. (+7)
65 [GO] 2021―Feb―11 Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider Aurélie Najm, Alessia Alunno, Xavier Mariette, Benjamin Terrier, Gabriele De Marco, Jenny Emmel, et al. (+3)
66 [GO] 2021―Feb―09 Correction: High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV brasil registry
67 [GO] 2021―Feb―06 Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial Maria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, Natalia B Amaral, Pamella Indira Menezes, Saulo Musse Dib, et al. (+28)
68 [GO] 2021―Jan―28 High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry Claudia Diniz Lopes Marques, Adriana Maria Kakehasi, Marcelo Medeiros Pinheiro, Licia Maria Henrique Mota, Cleandro Pires Albuquerque, Carolina Rocha Silva, et al. (+26)
69 [GO] 2021―Jan―21 Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases Rebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, Andreas Krause, Hanns-Martin Lorenz, Alexander Pfeil, et al. (+8)
70 [GO] 2021―Jan―17 Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe? Cristiana Sieiro Santos, Xenia Cásas Férnandez, Clara Moriano Morales, Elvira Díez Álvarez, Carolina Álvarez Castro, Alejandra López Robles, Trinidad Pérez Sandoval
71 [GO] 2021―Jan―05 Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry Bente Glintborg, Dorte Vendelbo Jensen, Sara Engel, Lene Terslev, Mogens Pfeiffer Jensen, Oliver Hendricks, et al. (+15)
72 [GO] 2020―Dec―28 Evidences for a protective role of vitamin D in COVID-19 Maurizio Cutolo, Sabrina Paolino, Vanessa Smith
73 [GO] 2020―Oct―21 Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline Serena Bugatti, Ludovico De Stefano, Francesca Bobbio-Pallavicini, Carlomaurizio Montecucco
74 [GO] 2020―Oct―03 Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey Bella Mehta, Deanna Jannat-Khah, Mark Alan Fontana, Carine J Moezinia, Carol A Mancuso, Anne R Bass, et al. (+4)
75 [GO] 2020―Sep―02 National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD Rebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, Bimba F Hoyer, Andreas Krause, Hanns-Martin Lorenz, et al. (+7)
76 [GO] 2020―Aug―06 Reactive arthritis after COVID-19 infection Keisuke Ono, Mitsumasa Kishimoto, Teppei Shimasaki, Hiroko Uchida, Daisuke Kurai, Gautam A Deshpande, et al. (+2)
77 [GO] 2020―Jul―01 Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic Isabelle Koné-Paut, Rolando Cimaz
78 [GO] 2020―Jun―25 Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view Vasco C Romão, Inês Cordeiro, Carla Macieira, Filipa Oliveira-Ramos, José Carlos Romeu, Carlos Miranda Rosa, et al. (+4)
79 [GO] 2020―May―18 Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin Alessia Alunno, Francesco Carubbi, Javier Rodríguez-Carrio
 [1] 

79 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec